Literature DB >> 29490248

Role of the Disulfide Bond in Prion Protein Amyloid Formation: A Thermodynamic and Kinetic Analysis.

Ryo Honda1.   

Abstract

Prion diseases are associated with the structural conversion of prion protein (PrP) to a β-sheet-rich aggregate, PrPSc. Previous studies have indicated that a reduction of the disulfide bond linking C179 and C214 of PrP yields an amyloidlike β-rich aggregate in vitro. To gain mechanistic insights into the reduction-induced aggregation, here I characterized how disulfide bond reduction modulates the protein folding/misfolding landscape of PrP, by examining 1) the equilibrium stabilities of the native (N) and aggregated states relative to the unfolded (U) state, 2) the transition barrier separating the U and aggregated states, and 3) the final structure of amyloidlike misfolded aggregates. Kinetic and thermodynamic experiments revealed that disulfide bond reduction decreases the equilibrium stabilities of both the N and aggregated states by ∼3 kcal/mol, without changing either the amyloidlike aggregate structure, at least at the secondary structural level, or the transition barrier of aggregation. Therefore, disulfide bond reduction modulates the protein folding/misfolding landscape by entropically stabilizing disordered states, including the U and transition state of aggregation. This also indicates that the equilibrium stability of the N state, but not the transition barrier of aggregation, is the dominant factor determining the reduction-induced aggregation of PrP.
Copyright © 2017 Biophysical Society. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29490248      PMCID: PMC5984966          DOI: 10.1016/j.bpj.2017.12.031

Source DB:  PubMed          Journal:  Biophys J        ISSN: 0006-3495            Impact factor:   4.033


  44 in total

1.  The α-helical C-terminal domain of full-length recombinant PrP converts to an in-register parallel β-sheet structure in PrP fibrils: evidence from solid state nuclear magnetic resonance.

Authors:  Robert Tycko; Regina Savtchenko; Valeriy G Ostapchenko; Natallia Makarava; Ilia V Baskakov
Journal:  Biochemistry       Date:  2010-11-09       Impact factor: 3.162

2.  Seeded conversion of recombinant prion protein to a disulfide-bonded oligomer by a reduction-oxidation process.

Authors:  Sangho Lee; David Eisenberg
Journal:  Nat Struct Biol       Date:  2003-08-03

3.  FTIR reveals structural differences between native beta-sheet proteins and amyloid fibrils.

Authors:  Giorgia Zandomeneghi; Mark R H Krebs; Margaret G McCammon; Marcus Fändrich
Journal:  Protein Sci       Date:  2004-11-10       Impact factor: 6.725

4.  Fibril conformation as the basis of species- and strain-dependent seeding specificity of mammalian prion amyloids.

Authors:  Eric M Jones; Witold K Surewicz
Journal:  Cell       Date:  2005-04-08       Impact factor: 41.582

5.  Reversible conversion of monomeric human prion protein between native and fibrilogenic conformations.

Authors:  G S Jackson; L L Hosszu; A Power; A F Hill; J Kenney; H Saibil; C J Craven; J P Waltho; A R Clarke; J Collinge
Journal:  Science       Date:  1999-03-19       Impact factor: 47.728

6.  In vitro conversion of full-length mammalian prion protein produces amyloid form with physical properties of PrP(Sc).

Authors:  Olga V Bocharova; Leonid Breydo; Alexander S Parfenov; Vadim V Salnikov; Ilia V Baskakov
Journal:  J Mol Biol       Date:  2004-12-19       Impact factor: 5.469

Review 7.  Disulfide bonds and protein folding.

Authors:  W J Wedemeyer; E Welker; M Narayan; H A Scheraga
Journal:  Biochemistry       Date:  2000-04-18       Impact factor: 3.162

8.  Metastability of native proteins and the phenomenon of amyloid formation.

Authors:  Andrew J Baldwin; Tuomas P J Knowles; Gian Gaetano Tartaglia; Anthony W Fitzpatrick; Glyn L Devlin; Sarah Lucy Shammas; Christopher A Waudby; Maria F Mossuto; Sarah Meehan; Sally L Gras; John Christodoulou; Spencer J Anthony-Cahill; Paul D Barker; Michele Vendruscolo; Christopher M Dobson
Journal:  J Am Chem Soc       Date:  2011-08-19       Impact factor: 15.419

9.  Promotion of insulin aggregation by protein disulfide isomerase.

Authors:  Ryosuke Maeda; Kazuyoshi Ado; Naohiro Takeda; Yoshihiro Taniguchi
Journal:  Biochim Biophys Acta       Date:  2007-08-29

10.  The native state of prion protein (PrP) directly inhibits formation of PrP-amyloid fibrils in vitro.

Authors:  Ryo P Honda; Kazuo Kuwata
Journal:  Sci Rep       Date:  2017-04-03       Impact factor: 4.379

View more
  5 in total

1.  Hypoxia Induces DPSC Differentiation versus a Neurogenic Phenotype by the Paracrine Mechanism.

Authors:  Simona Delle Monache; Fanny Pulcini; Francesca Santilli; Stefano Martellucci; Costantino Santacroce; Jessica Fabrizi; Adriano Angelucci; Maurizio Sorice; Vincenzo Mattei
Journal:  Biomedicines       Date:  2022-05-03

2.  Cysteine oxidation triggers amyloid fibril formation of the tumor suppressor p16INK4A.

Authors:  Christoph Göbl; Vanessa K Morris; Loes van Dam; Marieke Visscher; Paulien E Polderman; Christoph Hartlmüller; Hesther de Ruiter; Manuel Hora; Laura Liesinger; Ruth Birner-Gruenberger; Harmjan R Vos; Bernd Reif; Tobias Madl; Tobias B Dansen
Journal:  Redox Biol       Date:  2019-09-03       Impact factor: 11.799

Review 3.  Regulation of Functional Protein Aggregation by Multiple Factors: Implications for the Amyloidogenic Behavior of the CAP Superfamily Proteins.

Authors:  Jie Sheng; Nick K Olrichs; Bart M Gadella; Dora V Kaloyanova; J Bernd Helms
Journal:  Int J Mol Sci       Date:  2020-09-07       Impact factor: 5.923

Review 4.  Physiological function of myocilin and its role in the pathogenesis of glaucoma in the trabecular meshwork (Review).

Authors:  Hongwei Wang; Mingzhe Li; Zhenzhen Zhang; Haifeng Xue; Xing Chen; Yong Ji
Journal:  Int J Mol Med       Date:  2018-11-20       Impact factor: 4.101

5.  Amyloid formation of fish β-parvalbumin involves primary nucleation triggered by disulfide-bridged protein dimers.

Authors:  Tony E R Werner; David Bernson; Elin K Esbjörner; Sandra Rocha; Pernilla Wittung-Stafshede
Journal:  Proc Natl Acad Sci U S A       Date:  2020-10-22       Impact factor: 11.205

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.